AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study in 51 cases

Human Pathology

Volumn 28, Issue 3, 1997, Pages 367-374

  Camilleri Broet S ^b   Davi, F ^b   Feuillard, J ^b   Seilhean, D ^b   Michiels, J F ^b   Brousset, P ^b   Epardeau, B ^b   Navratil, E ^b   Mokhtari, K ^b   Bourgeois, C ^b   Marelle, L ^b   Raphael M ^b   Hauw, J J ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

acquired immunodeficiency syndrome; bcl 2; Epstein Barr virus; primary brain lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BRAIN LYMPHOMA; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE STATUS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS LATENCY;

EID: 12644296991     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90137-4     Document Type: Article

References (43)

1. Beral V, Paterman T, Berkelman R, et al: AIDS-associated non-Hodgkin lymphoma. Lancet 337:805-809, 1991
2. Anders K, Guerra W, Tomiyasu U, et al: The neuropathology of AIDS: UCLA experience and review. Am J Pathol 124:537-558, 1986
3. Dickson D, Belman A, Park Y, et al: APMIS 8(suppl):40-57, 1989
4. Gray F, Geny C, Lionnet F, et al: Neuropathological study of 135 adult cases of acquired immune deficiency syndrome (AJDS). Ann Pathol 11:236-247, 1991
5. Hénin D, Duyckaerts C, Chaunu MP, et al: Neuropathological findings in 31 cases of acquired immunodeficiency syndrome (AIDS). Rev Neurol 143:631-642, 1987
6. Mac-Mahon EME, Glass JD, Hayward SD, et al: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338:969-973, 1991
7. Seilhean D, De Girolami U, Hénin D, et al: The neuropathology of AIDS: The Salpétrière experience and revieuw of the literature, 1981-1993, in Weinstein RS (ed): Advances in Pathology and Laboratory Medicine, vol 7. St. Louis, Mosby-Year Book, 1994
8. Hamilton-Dutoit S, Raphael M, Audoin J, et al: In-situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 82:619-624, 1993
9. Ambinder R, Lambe B, Mann R, et al: Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Mol Cell Probes 4:397-407, 1990
10. Bashir RM, Harris NL, Hochberg FH, et al: Detection of Epstein-Barr virus in CNS lymphomas by in situ hybridization. Neurology 39:813-817, 1989
11. Geddes JF, Bhattacharjee MB, Savage K, et al: Primary cerebral lymphoma: A study of 47 cases probed for Epstein-Barr virus genome. J Clin Pathol 45:587-590, 1992
12. Itoyama T, Sadamori N, Tsutsumi K, et al: Primary central nervous system lymphomas: Immunophenotypic, virologie and cytogenetic findings of the three patients without immune defects. Cancer 73:455-463, 1994
13. Rouah E, Rogers BB, Wilson DR, et al: Demonstration of Epstein-Barr virus in primary central nervous system lymphoma by the polymerase chain reaction and in situ hybridization. HUM PATHOL 21:545-550, 1990
14. De Girolami U, Smith TW, Hénin D, et al: Neuropathology in acquired immunodeficiency syndrome. Arch Pathol Lab Med 114:643-655, 1990
15. Morgello S: Epstein-Barr and human immunodeficiency syndrome-related primary central nervous lymphoma. Am J Pathol 141:441-450, 1992
16. Camilleri-Broët S, Feuillard J, Davi F, et al: High expression of LMP1 Epstein-Barr virus latency protein and bcl-2 oncoprotein in AIDS-related primary brain lymphomas. Blood 86:432-435, 1995
17. National Cancer Institute-Sponsored Study of Classification of Non-Hodgkin's Lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 49:2112-2135, 1982
18. Lennert K, Feller A: Histopathology of Non-Hodgkin's Lymphomas (ed 2). New York, NY, Springer-Verlag, 1992
19. Lee Harris N, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoids neoplasms: A proposal from the international lymphoma study group. Blood 84:1361-1392, 1994
20. Gribben J, Freedman A, Woo S, et al: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275-3280, 1991
21. Delecluse HJ, Raphael M, Felman P, et al: Variable morphology of HIV associated lymphomas with c-myc rearrangement. Blood 82:552-563, 1993
22. Polack A, Hartl G, Zimber U, et al: A complete set of overlapping cosmid clones of M-ABA virus derived from nasopharyngeal carcinoma and its similarity to other Epstein-Barr virus isolates. Gene 27:279-288, 1984
23. Kremmer E, Kranz B, Hille A, et al: Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). Virology 208:336, 1995
24. Hamilton-Dutoit S, Rea D, Raphael M, et al: Epstein-Barr virus latent gene expression and tumor cell phenotype in AIDS-related non-Hodgkin's lymphoma. Am J Pathol 143:1072-1085, 1993
25. Goldstein JD, Dickson DW, Moser FG, et al: Primary central nervous system lymphoma in acquired immune deficiency syndrome: A clinical and pathologic study with results of treatment with radiation. Cancer 67:2756-2765, 1991
26. Iglesias-Rosas JR, Bantz B, Adler T, et al: Cerebral lymphoma in AIDS: Clinical, radiological, neuropathological and immunological study. Clin Neuropathol 10:65-72, 1991
27. Marelle L, Raphael M, Henin D, et al: Les lymphomes cErEbraux du SIDA: AIDS-related brain lymphomas: Clinical study and clinico-pathological correlations. Rev Neurol 150:123-132, 1994
28. Schwechheimer K, Braus DF, Schwarzkopf G, et al: Polymorphous high grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas: Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies. Am J Surg Pathol 18:931-937, 1994
29. Auperin I, Mikol J, Oksenhendler E, et al: Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: Expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathology Applied Neurobiology 20:243-252, 1994
30. Raphael M, Gentilhomme O, Tulliez M, et al: Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immune deficiency syndrome. Arch Pathol Lab Med 115:15-20, 1991
31. Rowe M, Lear AL, Groom-Carter D, et al: Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122-131, 1992
32. Henle G, Henle W, Diel V: Relation of Burkitt's tumor-associated herpes-type virus to infection mononucleosis. Proc Natl Acad Sci U S A 59:94-101, 1968
33. De Luca A, Antinori A, Cingolani A, et al: Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 90:844-849, 1995
34. Cohen JI, Wang F, MannickJ, et al: Epstein-barr virus nuclear protein 2 mutation is a key determinant of lymphocytes transformation and transactivation. Proc Nad Acad Sci U S A 86:9558-9562, 1989
35. Wang D, Liebowitz D, Kieff E: An EBV membran protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840, 1985
36. Kerr BM, Lear AL, Rowe M, et al: Three transcriptionally distinct forms of Epstein Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology 187:189-201, 1992
37. Hockenbery D, Nunez G, Milliman C, et al: BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
38. Korsmeyer S: BCL-2: A repressor of lymphocyte death. Immunol Today 13:285-288, 1992
39. Finke J, Fritzen R, Ternes P, et al: Expression of BCL-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood 80:459-469, 1992
40. Henderson S, Rowe M, Gregory C, et al: Induction of BCL-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115, 1991
41. Kondo E, Yoshino T, Nomura S, et al: bcl-2 regulation in normal resting lymphocytes and lymphoblastes. Jpn J Cancer Res 85:260-265, 1994
42. Claviez A, Tiemann M, Peters J, et al: The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood. Ann Hematol 68:61-66, 1994
43. Khan G, Gupta RK, Coates PJ, et al: Epstein-Barr virus infection and BCL-2 proto-oncogene expression separate events in the pathogenesis of Hodgkin's disease? Am J Pathol 143:1270-1274, 1993